Services Offered
Look Better
Choose one of the procedures below to view more information about each.

Latisse Eyelash Growth

About | Photos | FAQs
Latisse Facts
LATISSE™ (bimatoprost ophthalmic solution) 0.03%—the first and only
treatment approved by the FDA indicated to treat hypotrichosis of the eyelashes
by increasing their growth including length, thickness, and darkness. Latisse Before

Latisse

LATISSE™ solution was evaluated for its effect on overall eyelash prominence in a multicenter, double-masked, randomized, vehicle-controlled, parallel study including 278 adult patients for 4 months of treatment. The primary efficacy endpoint in this study was an increase in overall eyelash prominence as measured by at least a 1-grade increase on the 4-point Global Eyelash Assessment (GEA) scale*, from baseline to the end of the treatment period.

  • LATISSE™ increased eyelash prominence
    • Statistically significant differences vs vehicle seen at 8, 12, and 16 weeks
    • 78% of patients experienced an improvement in overall eyelash prominence by week 16 vs 18% for vehicle
  • LATISSE™ improved eyelash growth from baseline as measured by digital-image analysis assessing eyelash length, fullness/thickness, and darkness
    • Statistically significantly more pronounced in the bimatoprost group at weeks 8, 12, and 16
Latisse PercentagesLATISSE™ solution is applied once nightly directly to the skin of the upper eyelid margin at the base of the eyelashes using supplied, FDA-approved sterile applicators.
About | Photos | FAQs
View Aesthetic Procedures